BioCentury | Sep 11, 2008
Distillery Therapeutics

This Week in Therapeutics

...expression. RGS10 knockdown in dopaminergic cells enhanced the cells' vulnerability to microglial-derived inflammatory mediators. LPS-treated RGS10-deficient...
...littermates. Next steps include investigating the normal function of RGS10 in the brain and validating RGS10...
Items per page:
1 - 1 of 1